Profiel
Stephanie Vigue worked as a Finance Director at Sesen Bio, Inc. She then worked as a Manager-Corporate Accounting at Spectrum Pharmaceuticals, Inc. from 2014 to 2017.
In 2020, she worked as a Manager-Corporate Accounting & Controller at The Fi Co. Ms. Vigue received an undergraduate degree from Husson University.
Eerdere bekende functies van Stephanie Vigue
| Bedrijven | Functie | Einde |
|---|---|---|
| The Fi Co. | Comptroller/Controller/Auditor | 01-09-2021 |
| SPECTRUM PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01-09-2017 |
| CARISMA THERAPEUTICS, INC. | Director of Finance/CFO | - |
Opleiding van Stephanie Vigue
| Husson University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SPECTRUM PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Sesen Bio, Inc.
 Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Sesen Bio, Inc. is a late-stage clinical company, which engages in the development of targeted fusion protein therapeutics. It offers Vicineum and Proxinium, which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver, and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA. | Health Technology |
| The Fi Co. |
